Lucia Trotta

Dr. Lucia Trotta

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2021 in Current Cardiology Reports
Verified
Journal Article
Closed access
PDF file
EBEmanuele Bizzi
Emanuele Bizzi
LTLucia Trotta
Lucia Trotta
MPMassimo Pancrazi
Massimo Pancrazi
MNMariangela Nivuori
Mariangela Nivuori
VGValeria Giosia
Valeria Giosia
ABAntonio Brucato
Antonio Brucato


6 May 2024 in Diseases
Verified
Journal Article
Open access
PDF file
Valeria CalcaterraValeria Calcaterra
Valeria Calcaterra
SZSara Zanelli
Sara Zanelli
AFAndrea Foppiani
Andrea Foppiani
Elvira VerduciElvira Verduci
Elvira Verduci
BBBeatrice Benatti
Beatrice Benatti
Gianvincenzo ZuccottiGianvincenzo Zuccotti
Gianvincenzo Zuccotti
Long COVID affects both children and adults, including subjects who experienced severe, mild, or even asymptomatic SARS-CoV-2 infection. We have provided a comprehensive overview of the incidence, clinical characteristics, risk factors, and outcomes of persistent COVID-19 symptoms in both children and adults, encompassing vulnerable populations, such as pregnant women and oncological patients. Our objective is to emphasize the critical significance of adopting an integrated approach for the early detection and appropriate management of long COVID. The incidence and severity of long COVID symptoms can have a significant impact on the quality of life of patients and the course of disease in the case of pre-existing pathologies. Particularly, in fragile and vulnerable patients, the presence of PASC is related to significantly worse survival, independent from pre-existing vulnerabilities and treatment. It is important try to achieve an early recognition and management. Various mechanisms are implicated, resulting in a wide range of clinical presentations. Understanding the specific mechanisms and risk factors involved in long COVID is crucial for tailoring effective interventions and support strategies. Management approaches involve comprehensive biopsychosocial assessments and treatment of symptoms and comorbidities, such as autonomic dysfunction, as well as multidisciplinary rehabilitation. The overall course of long COVID is one of gradual improvement, with recovery observed in the majority, though not all, of patients. As the research on long-COVID continues to evolve, ongoing studies are likely to shed more light on the intricate relationship between chronic diseases, such as oncological status, cardiovascular diseases, psychiatric disorders, and the persistent effects of SARS-CoV-2 infection. This information could guide healthcare providers, researchers, and policymakers in developing targeted interventions.

19 March 2025 in European Journal of Internal Medicine
Verified
Journal Article
Open access
RMRuggiero Mascolo
Ruggiero Mascolo
Maddalena Alessandra WuMaddalena Alessandra Wu
Maddalena Alessandra Wu
SBSilvia Berra
Silvia Berra
MVMatteo Vidali
Matteo Vidali
MPMassimo Pancrazi
Massimo Pancrazi
ABAntonio Brucato
Antonio Brucato
Differences in recurrent pericarditis with normal vs. elevated C-reactive protein (CRP) are unknown. We studied 448 patients with recurrent or incessant pericarditis. CRP levels <10 mg/L were considered normal. Forty-one patients with normal CRP were tested for interleukin 6 (IL-6), serum amyloid A (SAA) and soluble urokinase plasminogen activator receptor (suPAR). Among the cohort (median age 43 years, 48.4% females), 336 patients (75%) had elevated CRP, while 112 (25%) had normal levels. CRP-negative patients were younger (38.6 vs. 43.5 years, p=0.007) and predominantly female (67.9% vs. 42.0%, p<0.001). They presented less often with fever (23.2% vs. 74.1%, p<0.001), pleural involvement (7.1% vs. 61.6% p<0.001), and neutrophilic leucocytosis (WBC 6760 vs. 12315/µL, p<0.001). Pericardiocentesis was performed rarely in CRP-negative patients (2.7% vs. 13.4%, p=0.001). Recurrence rates were similar (5.4 vs. 5.5/100 months-patient, p=0.918). Among CRP-negative patients, 53 (47.3%) had an incessant course characterized by persistent symptoms (pain and tachycardia); abnormal instrumental findings included ECG changes (28.6%), mild pericardial effusion (86.6%), and cardiac magnetic resonance evidence of effusion/oedema/late gadolinium enhancement (43.7%). Anakinra was administered to 48 CRP-positive (14.3%) and 10 CRP-negative patients (8.9%), leading to good responses with discontinuation of NSAIDs and corticosteroids in 39/48 (81.2%) and 5/10 (50.0%), respectively. Among the 41 CRP-negative patients tested, IL-6 and suPAR levels were always normal, while SAA was elevated in 17.1%. Pericarditis with normal CRP exhibits distinct clinical and laboratory features, often presenting with an incessant course. Although rarely elevated, SAA may help to identify inflammation beyond CRP.

1 July 2025 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
LTLucia Trotta
Lucia Trotta
RMRuggiero Mascolo
Ruggiero Mascolo
VMVartan Mardygan
Vartan Mardygan
ACAndreja Cerne Cercek
Andreja Cerne Cercek
ACAnne-Marie Claveau
Anne-Marie Claveau
ABAntonio Brucato
Antonio Brucato

9 September 2024 in Journal of the American Geriatrics Society
Verified
Journal Article
Open access
EBEmanuele Bizzi
Emanuele Bizzi
FCFrancesco Cavaleri
Francesco Cavaleri
RMRuggiero Mascolo
Ruggiero Mascolo
Edoardo ConteEdoardo Conte
Edoardo Conte
SMStefano Maggiolini
Stefano Maggiolini
MIMassimo Imazio
Massimo Imazio
Background: Current guidelines for the diagnosis and treatment of pericarditis refer to the general adult population. Few and fragmentary data regarding recurrent pericarditis in older adults exist. Objective of the Study: Given the absence of specific data in scientific literature, we hypothesized that there might be clinical, laboratory and outcome differences between young adults and older adults affected by idiopathic recurrent pericarditis. Materials and Methods: We performed an international multicentric retrospective cohort study analyzing data from patients affected by recurrent pericarditis (idiopathic or post‐cardiac injury) and referring to tertiary referral centers. Clinical, laboratory, and outcome data were compared between patients younger than 65 years (controls) and patients aged 65 or older. Results: One hundred and thirty‐three older adults and 142 young adult controls were enrolled. Comorbidities, including chronic kidney diseases, atrial fibrillation, and diabetes, were more present in older adults. The presenting symptom was dyspnea in 54.1% of the older adults versus 10.6% in controls ( p < 0.001); pain in 32.3% of the older adults versus 80.3% of the controls ( p < 0.001). Fever higher than 38°C was present in 33.8% versus 53.5% ( p = 0.001). Pleural effusion was more prevalent in the older adults (55.6% vs 34.5%, p < 0.001), as well as severe pericardial effusion (>20 mm) (24.1% vs 12.7%, p = 0.016) and pericardiocentesis (16.5% vs 8.5%, p = 0.042). Blood leukocyte counts were significantly lower in the older adults (mean + SE: 10,227 + 289/mm 3 vs 11,208 + 285/mm 3 , p = 0.016). Concerning therapies, NSAIDS were used in 63.9% of the older adults versus 80.3% in the younger ( p = 0.003), colchicine in 76.7% versus 87.3% ( p = 0.023), corticosteroids in 49.6% versus 26.8% ( p < 0.001), and anakinra in 14.3% versus 23.9% ( p = 0.044). Conclusions: Older adults affected by recurrent pericarditis show a different clinical pattern, with more frequent dyspnea, pleural effusion, severe pericardial effusion, and lower fever and lower leukocyte count, making the diagnosis sometimes challenging. They received significantly less NSAIDs and colchicine, likely due to comorbidities; they were also treated less commonly with anti‐IL1 agents, and more frequently with corticosteroids.